Published : Sep-2019
No. of Pages : 159
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials 17
Clinical Trials by Phase in G7 Countries 19
Clinical Trials in G7 Countries by Trial Status 20
Clinical Trials by E7 Countries: Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials 22
Clinical Trials by Phase in E7 Countries 24
Clinical Trials in E7 Countries by Trial Status 25
Clinical Trials by Phase 27
In Progress Trials by Phase 28
Clinical Trials by Trial Status 29
Clinical Trials by End Point Status 31
Subjects Recruited Over a Period of Time 32
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Bacterial Vaginosis Therapeutics Clinical Trials 36
Prominent Drugs 37
Latest Clinical Trials News on Bacterial Vaginosis 38
Aug 08, 2019: Dare announces presentation of positive clinical findings for vaginal administration of novel formulation of clindamycin phosphate for the treatment of bacterial vaginosis at the 2019 Annual Meeting of the Infectious Diseases Society for Obstetrics and Gynecology 38
Clinical Trial Profile Snapshots 39
Appendix 158
Abbreviations 158
Definitions 158
Research Methodology 159
Secondary Research 159
About GlobalData 160
Contact Us 160
Source 161
List of Tables
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Region, 2019* 8
Bacterial Vaginosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Bacterial Vaginosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
Bacterial Vaginosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
Bacterial Vaginosis Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
Bacterial Vaginosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
Bacterial Vaginosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2019* 16
Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, G7 Countries (%), 2019* 18
Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 21
Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, E7 Countries (%), 2019* 23
Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24
Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 26
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Phase, 2019* 27
Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 28
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 30
Bacterial Vaginosis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 31
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 32
Bacterial Vaginosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 33
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 35
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37
List of Figures
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
Bacterial Vaginosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Bacterial Vaginosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
Bacterial Vaginosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
Bacterial Vaginosis Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
Bacterial Vaginosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15
Bacterial Vaginosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2019* 16
Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, G7 Countries (%), 2019* 17
Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, E7 Countries (%), 2019* 22
Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24
Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Phase (%), 2019* 27
Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 28
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29
Bacterial Vaginosis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 31
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 32
Bacterial Vaginosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 33
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37
GlobalData Methodology 159
